Neuroimmunomodulation is a peer-reviewed english-language open-access journal published by Karger Publishers in Switzerland, operating under an open-access model since 2023. The journal covers Internal medicine.
Authors are required to pay an article processing charge to publish in Neuroimmunomodulation; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY-NC license (see other journals using this license).
Keywords
neuroinflammation, psychoneuroimmunology, nervous system, immune system, endocrine system, immunomodulation
At a glance
- Publisher
- Karger Publishers
- Country
- Switzerland
- Primary language
- English
- License
- CC BY-NC
- Peer review
- Anonymous peer review
- OA since
- 2023
ISSN
- 1021-7401
- electronic
- 1423-0216
Frequently asked questions
Is Neuroimmunomodulation peer-reviewed?
Yes — Neuroimmunomodulation operates a Anonymous peer review review process.
Does Neuroimmunomodulation charge an article processing charge (APC)?
Yes — refer to the journal's APC page for the current rate. A waiver policy is available for eligible authors.
What subjects does Neuroimmunomodulation publish?
Neuroimmunomodulation publishes research in Internal medicine.
What languages does Neuroimmunomodulation accept?
Neuroimmunomodulation accepts manuscripts in English.
What is the ISSN of Neuroimmunomodulation?
ISSN:
1021-7401 (print) · 1423-0216 (electronic).How do I submit a manuscript to Neuroimmunomodulation?
Submit through the journal's official portal: visit submission page →